Table 3.
Dietary intakes of study participants throughout the study.
| Placebo group1 (n = 29) | Vitamin D group2 (n = 30) | P ∗ | |
|---|---|---|---|
| Calorie at study baseline (kcal/d) | 3302.7 ± 889.2 | 3373.2 ± 1501 | 0.8 |
| Calorie at the end of the trial (kcal/d) | 2630.4 ± 964.5 | 2444.3 ± 1079.6 | 0.4 |
| Carbohydrate at study baseline (gr/d) | 282.2 ± 74.6 | 299.9 ± 121.7 | 0.6 |
| Carbohydrate at the end of the trial (gr/d) | 235 ± 83.4 | 243.8 ± 111.5 | 0.7 |
| Protein at study baseline (gr/d) | 89.2 ± 37 | 84.2 ± 38.1 | 0.5 |
| Protein at the end of the trial (gr/d) | 82 ± 42.3 | 69.4 ± 37.5 | 0.6 |
| Fat at study baseline (gr/d) | 198.4 ± 93.1 | 211.3 ± 127.3 | 0.8 |
| Fat at the end of the trial (gr/d) | 143.5 ± 89.7 | 136.3 ± 78.2 | 0.8 |
| SAFs at study baseline (gr/d) | 36.2 ± 15.2 | 38 ± 21.1 | 0.7 |
| SAFs at the end of the trial (gr/d) | 29.2 ± 12.6 | 28 ± 14 | 0.7 |
| PUFA at study baseline (gr/d) | 114.1 ± 59.7 | 107.2 ± 67.8 | 0.3 |
| PUFA at the end of the trial (gr/d) | 75.7 ± 56.2 | 70.2 ± 55.5 | 0.5 |
| MUFA at study baseline (gr/d) | 47.7 ± 21.7 | 63.3 ± 57.5 | 0.8 |
| MUFA at the end of the trial (gr/d) | 39.5 ± 24.8 | 39.3 ± 28.1 | 0.6 |
| Vitamin D at study baseline (μg/d) | 0.44 ± 1 | 1.14 ± 1.8 | 0.5 |
| Vitamin D at the end of the trial (μg/d) | 0.33 ± 0.96 | 1.09 ± 2.3 | 0.4 |
| Calcium at study baseline (mg/d) | 644 ± 411.5 | 600 ± 376.5 | 0.6 |
| Calcium at the end of the trial (mg/d) | 474.8 ± 343.3 | 523.8 ± 332.5 | 0.4 |
| Iron at study baseline (mg/d) | 17.5 ± 6 | 15.37 ± 7 | 0.1 |
| Iron at the end of the trial (mg/d) | 14.4 ± 6.3 | 12.15 ± 5 | 0.1 |
| Mg at study baseline (mg/d) | 237.7 ± 134.8 | 22 ± 128.9 | 0.4 |
| Mg at the end of the trial (mg/d) | 195.9 ± 100.2 | 166 ± 83.9 | 0.2 |
| Na at study baseline (mg/d) | 1721.2 ± 2248.9 | 1344.9 ± 1341.2 | 0.8 |
| Na at the end of the trial (mg/d) | 1265.3 ± 2003.7 | 921.6 ± 740.5 | 0.9 |
| Dietary fiber at study baseline (gr/d) | 21.9 ± 16.3 | 17.7 ± 10.8 | 0.4 |
| Dietary fiber at the end of the trial (gr/d) | 19.1 ± 16.8 | 14.4 ± 9.4 | 0.5 |
SFAs: saturated fatty acids; PUFAs: polyunsaturated fatty acids; MUFAs: monounsaturated fatty acids; Na: sodium; Mg: magnesium. 1Received placebo per day during 8 weeks. 2Received 2,000 IU vitamin D per day during 8 weeks. ∗Significant difference (P < 0.05). Data are presented as means ± SDs. ∗Obtained from independent-sample t-test.